Background: Aberrant activation of autophagy (proteinopathy) leads to neurodegeneration in various neurological disorders. Results: Compensatory basal autophagy is activated and genotoxins deregulate autophagy in the ubiquitin pathway-compromised Ataxia Telangiectasia (A-T) cells. Conclusion: Deregulation of autophagy is due to the elevated expression of ISG15 in A-T cells. Significance: Results highlight a causal contribution of a novel "ISG15 proteinopathy" in A-T neurodegeneration.
Activated ATM kinase phosphorylates several key proteins that initiate activation of the DNA damage checkpoints, cell cycle arrest, and DNA repair to favor cell survival (10) . Therefore, a defect in ATM has severe consequences in DNA damaged cells, especially in terminally differentiated cells such as neurons (11) . Indeed, a defective DNA repair pathway has been linked to the progressive neurodegeneration in A-T patients (11) (12) (13) (14) . However, whether the defect in DNA repair is solely responsible for neurodegeneration in A-T is still unclear.
Altered expression/mutations in genes involved in protein turnover pathways have been linked to neurodegeneration in other neurological diseases (15, 16) . Accumulation of misfolded protein deposits in affected brain regions are reported in neurodegenerative diseases including Alzheimer's, Parkinson's, Creutzfeldt-Jakob, and Huntington's disease (15, 16) . In most cases, proteinaceous deposits were composed of ubiquitin conjugates, suggesting a failure in their degradation via the ubiquitin/26S proteasome, the major cellular proteolytic machinery responsible for targeted destruction of short lived and abnormal proteins in mammalian cells (17) . Surprisingly, very little is known about the potential accumulation of nondegraded ubiquitylated proteins in neurons of A-T patients in spite of the fact that progressive neurodegeneration is a hallmark of A-T (12, 13) . Although some documented reports in the literature support such a possibility (18, 19) , the molecular events leading to the accumulation of non-degradable ubiquitylated proteins and the potential causal relationship to neuronal degeneration in A-T patients is largely unknown. On the other hand, our recent studies have demonstrated that the targeted proteasomemediated degradation is impaired in A-T cells (20) . The reduced protein turnover in A-T cells is associated with elevated expression of ISG15, a ubiquitin-like protein (Interferon stimulated gene 15 kDa) demonstrated to antagonize the ubiquitin pathway (20) .
ISG15 protein is a member of the UBL (ubiquitinlike protein) class of proteins (21, 22) . It is induced upon interferon treatment (23) . Intracellular ISG15 exists in two forms: (i) free and (ii) conjugated to target proteins. ISG15 is conjugated to its target proteins in an enzymatic cascade involving an E1 (UbE1L), E2 (UbcH8), and E3 (HERC5 and others) (21) (22) (23) . Free ISG15 has been suggested to have cytokine-like activity (23) . Conjugated ISG15 exerts its biological effect by inhibiting polyubiquitylation of cellular proteins (24) (25) (26) . Several groups have now demonstrated that ISG15 inhibits the ubiquitin pathway by modulating the activities of the ubiquitin E2/E3 ligases (27) (28) (29) (30) . Concurrently, ISG15 inhibits polyubiquitylation and degradation of cellular proteins in breast cancer and A-T cells (24) . In addition, the presence of the ISG15/ubiquitin inclusions were found in A-T human postmortem brain tissues (20) . Together, these results point toward the possibility that, like in other neurological diseases, ISG15-mediated defects in targeted protein turnover by the proteasome may contribute to the neuronal atrophy in A-T.
Compelling evidence now demonstrates that under conditions where proteasome function is compromised, the large ubiquitin containing protein aggregates are cleared by autophagy (31-34); a second major proteolytic pathway that targets destruction of long-lived cellular proteins, larger macromolecular complexes, and defective organelles through lysosomes (35, 36) . In the current study we demonstrate that the basal autophagy is activated in A-T cells impaired in the ubiquitin pathway due to the constitutively elevated ISG15 pathway. Additionally, genotoxins (UV and camptothecin (37, 38) ) lead to the aberrant autophagic flux (increased degradation of autophagy substrates) in A-T cells. Inhibition of autophagy at an early stage using 3-MA blocked UV-induced autophagic flux. In contrast, Bafl that inhibits autophagy at a late stage failed to block UV-induced autophagic flux in A-T cells. These results revealed that the over induction of autophagy may underlie aberrant autophagic flux in A-T cells. ISG15 shRNA that restored the proteasome function attenuated both basal and UVactivated autophagy in A-T cells. These findings in A-T fibroblast cells suggest that, in addition to the ATM-mediated defects in the DNA repair pathways, autophagic stress caused due to the "ISG15 proteinopathy" (ISG15-mediated defects in protein turnover pathways) in other lineages of A-T cells such as neurons may contribute to A-T phenotype of neurodegeneration. Tissue sections: Slides with paraffin-embedded sections of the same midbrain tissues described above were used in immunofluorescence study.
Experimental Procedures
Construction of lentiviral ISG15 shRNA stable transfectants of FT169A (A-T) cell-Preparation of lentiviral particles is described in (40) . Briefly, five shRNA constructs (TRCN0000007420-5) for the ISG15 in a pLKO1 vector and one control nontargeting shRNA lentiviral vector (SHC002V) were purchased from Sigma Aldrich. Amongst the five shRNA constructs tested, TRCN0000007422 NM_005101.1-295S1C1 shRNA that showed efficient ISG15 knocked-down (>75%) in FT169A cells was used for the production of lentiviral particles. Lentiviral particles were generated by transfecting HEK293T cells with the lentiviral shRNA vector (pLKO.1-Puro harboring ISG15 or SHC002V vector harboring control shRNA), together with the packaging (psPax2) and an envelope (pMD2.G) vector (addgene) using standard calcium phosphate precipitation as described in (41) . Six to eight hrs post transfections, cells were washed once and replenished with the fresh DMEM medium, and allowed to grow for additional 48 hrs. The viral supernatants were then harvested and filtered through a 0.45-μm pore size filter. For transduction, FT169A (A-T) cells (65,000 cells/ml) were plated in a 6 well tissue culture plate 24 hrs prior to the lentiviral infection. The next day, culture medium was replaced with the 1 ml of fresh medium containing 6.5 µg/ml of polybrene (Chemicon International). Cells were infected with lentiviral particles containing ISG15 or control shRNA and incubated in a tissue culture incubator overnight. After 12 hrs of incubation, all transduced cells were replenished with the fresh culture media without polybrene. Two days post-transduction, cells were split (1:5) and allowed to grow under normal conditions (37 0 C and 5% CO 2 ). Selection medium that contained 6.5 μg/ml puromycin dihydrochloride (Sigma) was then added to the cells 48 hrs after replating. Individual colonies were picked following 5 weeks of puromycin selection and screened for ISG15 expression by Western blotting analysis using anti-ISG15 antisera. 5 ) were transfected with a hemagglutinin (HA)-ubiquitin plasmid using the PolyFect transfection reagent (Qiagen) as described in (24) .
Twenty-four hrs after transfection, cells were treated with either proteasome inhibitor MG132 (1 µM) (Boston Biochemicals) or autophagy inhibitor Bafilomycin A1 (Bafl) (1 nM) (Sigma) or 3-Methyladenine (3-MA) (100 nM) for 18 hrs as indicated. Cells were exposed to UV radiation (25 mJoules, using BioRad GS Gene Linker TM UV Chamber) and/or left untreated. Cells were then allowed to recover in the presence of inhibitors for 3 hours. Cell lysis, SDS-PAGE, and immunoblotting analysis to detect HA-ubiquitin conjugated proteins using anti-HA antibodies was carried out as described above.
Immunofluorescence analysis in cells: LC3 expression. Cells (100,000/point) were cultured on fibronectin-coated glass coverslips. Next day, cells were fixed in 4% paraformaldehyde. After washing with phosphatebuffered saline (PBS) (2 x 5 min), cells were incubated with 100 µg/ml Digitonin for 15 min at room temperature. Cells were then washed with PBS (2 x 5 min) and immunostained for LC3 (MBL International Corporation) for 1 hr at room temperature. After washing with phosphatebuffered saline (PBS) ( 
Results

UV induces degradation of polyubiquitylated proteins in A-T but not in ATM+ cells-Previous studies using the FT169A (A-T) (ATM null;
henceforth referred to as A-T) and FT169A (ATM+) (ATM reconstituted FT169A; henceforth referred to as ATM+) isogenic pair of fibroblast cells have demonstrated that ISG15, a ubiquitin-like protein known to antagonize the ubiquitin pathway, is elevated and inhibits the ubiquitin pathway in A-T cells (24) .
The ubiquitin pathway plays a key role in ATMdependent DNA repair (42) . Because A-T cells are defective in both the DNA repair (due to the defective ATM kinase) (43) and ubiquitin (due to the constitutively elevated ISG15 pathway) pathways (20) , we opted to examine the effect of UV, a genotoxic stressor known to induce DNA damage, on the global protein polyubiquitylation and their subsequent degradation in A-T cells. As shown in Fig. 1 A, the steady state levels of the endogenous polyubiquitylated proteins and free ubiquitin rapidly decreased in A-T cells exposed to different doses of UV radiation and detected 3 hours post-radiation survival ( Fig. 1 A, left panel, compare lane 1 with lanes 2 and 3). By contrast, very little decrease in the steady state levels of polyubiquitylated proteins was seen in ATM+ cells under the same conditions ( Fig. 1 A, right panel, compare lane 1 with lanes 2 and 3). These results revealed that the steady-state levels of polyubiquitylated proteins are decreased in UVtreated A-T but not in ATM+ cells.
Decrease in the steady state levels of polyubiquitylated proteins could either be due to their increased deubiquitylation or increased degradation via the 26S proteasome. Also, the ubiquitin antibody used in the above experiment is known to cross-react with free ISG15/UCRP (44) , and ISG15 protein is elevated in A-T cells (20) . We therefore transfected an HA-ubiquitin construct then assessed the steady state levels of the HA-polyubiquitylated proteins (to rule out the possibility of protein polyubiquitylation vs protein polyISGlyation), in the absence or presence of the proteasome inhibitor MG132 (to rule out the possibility of protein deubiquitylation vs protein degradation), in UV treated A-T and ATM+ cells. Consistent with the results shown in Fig. 1 A, UV also induced degradation of HA-polyubiquitylated proteins in A-T cells ( Fig. 1 B, left panel, compare lanes 1 and 2). Intriguingly, MG132 failed to protect UV-induced decrease of HApolyubiquitylated proteins in A-T cells (left panel, lanes 3 and 4). UV also induced moderate degradation of HA-polyubiquitylated proteins in ATM+ cells ( Fig. 1 B, right panel, compare lanes 1 and 2). However, unlike in A-T cells, MG132 completely blocked the decrease of HApolyubiquitylated proteins in ATM+ cells exposed to UV (right panel, lanes 3 and 4). Inhibition of protein disappearance in MG132-treated ATM+ cells suggested that the UV-induced disappearance of HA-polyubiquitylated proteins in A-T cells is not due to their deubiquitylation but due to their degradation via the 26S proteasome. The MTT assay for cell survival revealed that the degradation of polyubiquitylated proteins was not due to the decreased viability of UV-treated A-T cells under our experimental conditions (data not shown). These results were intriguing because we previously demonstrated that degradation of polyubiquitylated proteins via the 26S proteasome is impaired in A-T but not in ATM+ cells (20) .
The autophagy pathway is induced as a compensatory mechanism to degrade cellular proteins in cells defective in the ubiquitin pathway (31) (32) (33) (34) . In addition the MG132 proteasome inhibitor induces autophagy (45, 46) . We therefore tested whether the UV-induced degradation of polyubiquitylated proteins is via autophagy in the ubiquitin-pathway ablated A-T cells. To test the involvement of autophagy, we employed the autophagy inhibitor Bafilomycin A1 (Bafl) (47) in this study. Similar to MG132, Bafl also failed to block UV-mediated degradation of polyubiquitylated proteins in A-T cells ( Fig. 1 B, left panel, lanes 5 and 6). In contrast, Bafl significantly blocked the decrease of HApolyubiquitylated proteins in ATM+ cells exposed to UV (right panel, lanes 5 and 6). We also assessed protein degradation in the presence of 50 nM Bafl and observed that even this high concentration of Bafl failed to protect UV-induced degradation of cellular proteins in A-T cells (data not shown). The results using ATM+ cells and inhibitors implies that the failure of Bafl and MG132 to block UV-induced degradation of the polyubiquitylated proteins in A-T cells is not due to the limiting concentration of MG132 and Bafl used in our experiment, as these inhibitors efficiently blocked the degradation of polyubiquitylated proteins in ATM+ cells. The bar graph shows average values (± SE) of % degradation of polyubiquitylated proteins measured from three independent experiments confirming reproducibility of the qualitative results shown in Fig. 1 B. Together, these results revealed that UV induces MG132-and Bafilomycin-resistant degradation of polyubiquitylated proteins in A-T but not in ATM+ cells.
To complement the results shown in Fig. 1 B, we used another construct that express HA-ubiquitin that can preferentially make polyubiquitin chains linked through Lys 48 on the substrates (20) . Similar results were obtained using this distinct HA-ubiquitin construct ( Fig. 1 C) ; we found that UV induces MG132-and Bafilomycin-resistant degradation of HA-Lys 48 -linked polyubiquitylated proteins in A-T but not in ATM+ cells.
To test the generality of this observation, we examined if the anticancer drug camptothecin (CPT), a genotoxic agent (37, (48) (49) (50) , known to sensitize A-T cells (37) , like UV, can induce degradation of polyubiquitylated proteins in A-T cells.
Similar to UV, CPT also induced degradation of endogenous polyubiquitylated proteins ( Fig. 1 D, lanes 1 and 2) (p < 0.0001), and Bafl failed to protect CPT-mediated degradation of polyubiquitylated proteins (Fig. 1 D, lanes 3 and  4) in A-T cells (p < 0.0001). These results imply that genotoxins such as UV and CPT induce aberrant degradation of polyubiquitylated cellular proteins in the proteasome function-ablated A-T cells.
Basal autophagy is activated in A-T cells impaired in the ubiquitin pathway-
Basal autophagy is activated in Atm knockout mice brains (51) . It is possible that basal autophagy is also activated and genotoxins deregulate activated autophagy leading to aberrant degradation of polyubiquitylated proteins in human A-T cells. To test this hypothesis, we first examined the status of endogenous LC3 puncta, a biological marker commonly used to trace induction of autophagy in mammalian cells (52) (53) (54) . As shown in Fig. 2 A, A-T cells showed a significant increase in LC3 puncta as compared to ATM+ cells (left panels). The bar graph in right panel shows the mean number of (± SEM) LC3-puncta counted per cell using Image J software. These results revealed that, like in Atm knockout mice, basal autophagy is activated in human A-T cells that are impaired in the ubiquitin pathway.
We also examined autophagy using Cyto-ID ® and LysoTracker Red stains. Cyto-ID ® selectively labels autophagic vacuoles (pre-autophagosomes, autophagosomes, and autophagolysosomes) and a fluorescent acidotropic probe LysoTracker Red labels acidic organelles such as lysosomes and autophagolysosomes (54) . Appearance of green dots indicated the formation of autophagosomes; red dots indicated lysosomes; and yellow dots in merged images (green dots that overlay red dots in merged images) indicated autophagolysosomes (autophagasomes fused with lysosomes). As shown in Fig. 2 B, increased numbers of bright green (compare panels 1 and 4) and red (compare panels 2 and 5) dots was seen in A-T compared to ATM+ cells, suggesting increased autophagic activity in A-T cells. In addition, there was a significant increase in yellow dots, indicating that there was a marked constitutive increase in autophagolysosomes in A-T compared to ATM+ cells (compare panels 3 and 6, and quantitative bar graph in Fig. 2 C) . Together, immunofluorescence data using anti-LC3 antibodies and Cyto-ID/LysoTrack Red dyes revealed that basal autophagy is activated in A-T cells. To the best of our knowledge, this is the first report demonstrating the detection of autophagolysosomes using combination of the Cyto-ID ® and LysoTrack Red dyes in live cells.
Degradation of autophagy substrates is deregulated in UV-exposed A-T cells-Because
degradation of proteasome substrates is deregulated in A-T cells, we assessed the degradation of the autophagy substrates (autophagic flux) LC3 and p62 in UV-exposed A-T and ATM+ cells (55) . As shown in Fig. 3 , UV induced degradation of LC3 and p62 (Figs. 3 A  and B, left panels, lanes 1 and 2) in A-T cells. The autophagy inhibitor Bafl failed to protect UVmediated degradation of LC3 and p62 in A-T cells (Figs. 3 A and B, left panels, lanes 3 and 4) . On the other hand, no apparent changes in LC3 and p62 levels were detected in ATM+ cells treated with UV in the absence or presence of Bafl (Figs.  3A and B, right panels) . The bar graphs (extreme right panels) show average (+/-SEM) degradation of LC3 (LC3-I and II) and p62 proteins in UVexposed A-T and ATM+ cells treated with Bafl from three independent experiments. These results revealed that, like the proteasome substrates ( Fig.  1) , UV also induces aberrant degradation of autophagy substrates in A-T cells.
We also monitored autophagic flux using Cyto-ID ® and LysoTrack Red dyes. Immunofluorescence results are shown in Fig. 4 A and the quantitation of the immunofluorescence data is shown in Fig. 4 
Induction of basal autophagy is a consequence of constitutively elevated ISG15 in A-T cells-
Previously we have shown that ISG15 siRNA restores impaired proteasome function suggesting the involvement of the constitutively elevated ISG15 pathway in inhibiting the ubiquitin pathway in A-T cells (20) . We speculated that if induction of basal autophagy compensates ISG15-impaired proteasome function, ISG15 siRNA should restore the proteasome function and suppress activated autophagy in A-T cells. To test whether this is indeed the case, we generated stable clones of To test if the autophagy pathway is restored, we measured LC3 puncta in ISG15-silenced A-T cells. As shown in Fig. 5 B, A-T/LV-control shRNA cells exhibited increased number of LC3-positive puncta (average # of 67 puncta/cell) as compared to A-T/LV-ISG15 shRNA cells (average number of 5 puncta/cell). These results revealed that basal autophagy is activated and activated autophagy is due to the elevated expression of ISG15 in A-T cells.
To further test whether silencing of ISG15 expression attenuated autophagy, we stained these cells with Cyto-ID ® and LysoTracker Red dye as described in Fig. 2 . The same criteria were used to judge autophagic activity in immunofluorescence analysis as described in Fig. 2 . As shown in Fig. 5 C, a decreased number of green and yellow dots was seen in A-T/LV-ISG15 shRNA (panels 4 and 6 and quantitative bar graph in Fig. 5 C) as compared to A-T/LV-control shRNA (panels 1 and 3 and quantitative bar graph in Fig. 5 C) cells, suggesting attenuation of autophagic activity in A-T/ISG15-shRNA cells. Together, immunofluorescence data using anti-LC3, Cyto-ID, and LysoTrack Red dyes revealed that, like in FT169A (A-T) cells (Fig. 3) , basal autophagic activity is increased in A-T/LV-control shRNA cells and activated autophagy is due to the elevated expression of ISG15 in A-T/LV control cells.
Degradation of autophagy substrates is restored in the ISG15-silenced A-T cells-
We next assessed whether ISG15 gene knock down restores autophagy and rescues UV-induced autophagic flux in A-T/LV-control/ISG15-shRNA stable clones. We found that UV also induced MG132 and Bafl-resistant degradation of LC3 and p62 in A-T/control-shRNA cells but not in A-T/ISG15-shRNA cells (Fig. 6, panels A and B) . The bar graph in Figs. 6 A and B (extreme right panels) show average (± SEM) degradation of LC3 (LC3-I and II) and p62 proteins in UV-exposed A-T/LVcontrol/ISG15 shRNA cells treated with Bafl from three independent experiments. These results further revealed that the constitutively elevated ISG15 pathway contributes to the UV-induced aberrant autophagic flux in A-T cells.
We also assessed autophagic flux using Cyto-ID ® and LysoTrack Red dyes as described in Fig. 4 . The same criteria were used to judge autophagic activity in immunofluorescence analysis as described for Fig. 4 . As seen in Fig. 7 
B)/treated (panel C) A-T/LV-control cells. This degradation was not due to the proteasome as MG132, a proteasome inhibitor failed to block UV-mediated degradation of proteins in A-T/LVcontrol shRNA cells (panel D).
Bafilomycin inhibits autophagy at a late stage (47) . We therefore tested whether 3-methyl adenine (3-MA), an autophagy inhibitor known to inhibit autophagy at early stage by inhibiting formation of autophagosomes (56) The autophagy pathway is activated in brains of human A-T patients-Astroglial cell dysfunction has been implicated in the pathogenesis of various neurological disorders (57) and ISG15 is elevated in A-T astrocytes (20) . We therefore looked for the evidence of autophagy induction in the A-T human brains. As shown in Fig. 9 A, a dramatic increase in both LC3 (autophagy marker)/GFAP (astrocytes marker) double-positive stained inclusions was seen in the mid-brain sections obtained from the A-T patient (right panel) [see green (LC3) and red (GFAP) color turning to yellow (GFAP and LC3 double inclusions) in merged images (see arrows)] Although LC3/GFAP inclusions were also present in brain sections of the normal individual (left panel), the intensity of the LC3/GFAP doublepositive staining was much higher in the brain section of the A-T patient as compared to the normal individual. Similar increases in the LC3/GFAP double-positive staining were noted in the brain sections of the two other A-T patients (data not shown).
We also examined tissue lysates of mid-brain regions (specifically containing substantia nigra) obtained postmortem from A-T human patients with confirmed A-T disease for autophagy induction by Western blotting using anti-LC3 antibodies (Fig. 9 B) . The presence of LC3-II form in brain tissue lysates is indicative of a strong induction of autophagy in these patients, as LC3-II form is an indicator of an active autophagy.
Together, these results suggested that autophagy is activated/impaired in A-T patients.
Discussion
Proteinopathies caused by molecular lesions in the ubiquitin pathway leading to the neuronal cell death is common in many neurological disorders (15, 16) and recently was implicated in A-T neurodegeneration (18) (19) (20) . It has been demonstrated that the elevated expression of ISG15, an antagonist of the ubiquitin/26S proteasome pathway (20, 24) , impairs the ubiquitin-mediated turnover of cellular proteins in A-T fibroblast cells (20) . Hence, it was suggested that as in other neurological disorders, ISG15-mediated proteinopathy in A-T neurons could lead to their death in A-T patients. The presence of ubiquitin-ISG15 inclusions in brain sections obtained postmortem from A-T human patients point toward such a possibility (20) . In the current study we show that autophagy is activated in the cells and brains of A-T patients. Interestingly, although a marked increase in LC3-positive inclusions was noted in the brain section of the A-T patient #1459 in immunofluorescence analysis (Fig. 9 A) , a moderate increase in the LC3-IIp was detected in tissue lysates of the same patient in Western analysis (Fig. 9 B, lane 3) . Two possibilities could explain these conflicting results: a) LC3 protein present in the inclusions are insoluble in the SDS sample buffer, and, consequently, are not detected on the Western blot; and/or b) LC3 protein is degraded during processing of the brain tissue. Nonetheless, the expression of LC3 protein in both immunofluorescence and immunoblotting analysis in this A-T patient reveals that the autophagy pathway is activated in A-T patient # 1459 and others. We have previously demonstrated that ISG15 and its conjugates are highly elevated in brain tissue lysates of the A-T patients # 1459, 1722, and 4663 shown in Fig. 9 B (20) . Our current result that autophagy is activated in the same patients, suggest that the induction of autophagy could be the consequence of the ISG15-mediated impairment of the proteasome pathway in the brain of these patients. Similar to A-T, ISG15 is also elevated in Amyotrophic Lateral Sclerosis (ALS) neurological disorder (58) . Hence, it appears that "ISG15 proteinopathy" may be a common underlying cause of neurological disorders, thus making our current study more significant.
Accumulation of non-degraded proteins has been shown to limit the viability of cells growing in culture in other studies (59) . Cellular substrates of the proteasome are also stabilized in A-T cells for which the ubiquitin-proteasome pathway has been compromised by ISG15 overexpression (20) . However, A-T cells generally grow normally in culture suggesting that the non-degraded proteins are eventually removed by an alternate mechanism. Our current findings suggest that the basally activated autophagy may limit the accumulation of non-degraded ubiquitin targets, thus preserving the viability of the A-T cells. This result is consistent with Barlow et However, the same concentration of Bafilomycin used in this experiment led to the accumulation of LC3 II in the serum-starved A-T and ATM+ cells (Desai, unpublished data). These results have revealed the effectiveness of Bafilomycin to inhibit induced autophagy A-T cells. Note that there is a difference between induced autophagy and basal autophagy. The induced autophagy is used to produce amino acids following starvation, while the basal autophagy is important for constitutive turnover of cytosolic components. It has been demonstrated that induced autophagic activity or total proteolysis is not sustained and decreases during prolonged starvation (35) . It is possible that due to the decreased rate of autophagic activity, LC3-II accumulates in serum-starved (starved for 24 hrs) A-T cells treated with Bafilomycin. On the other hand, under normal serum conditions (conditions used in the current manuscript), basal autophagy is sustained, consequently leading to continuous degradation of LC3 in Bafilomycin-treated A-T cells. The reason for the failure to accumulate these proteins in Bafilomycin-treated ATM+ cells is still not clear, but it could be due to the residual autophagic activity remaining in ATM+ cells; ATM+ cells are derived from A-T cells. Nevertheless, we consistently found significant amount of LC3II and p62 degradation in UVtreated A-T as compared to ATM+ cells suggesting increased autophagic flux in UV-treated A-T cells.
Although autophagy is activated, the steady state levels of polyubiquitylated proteins remained unaltered in metabolically stressed (nutritiondeprived) A-T cells (Desai, unpublished data) . In contrast, genotoxins induced aberrant degradation of polyubiquitylated proteins in A-T cells. These results suggest that A-T cells that are impaired in the ubiquitin pathway are able to handle metabolic stress but are unable to cope with the genotoxic stress. It is possible that genotoxic stress (e.g., UV) places a greater burden on autophagy through the accumulation of the non-degraded ubiquitylated proteins in the ubiquitin pathway-compromised A-T cells. Several cellular proteins are ubiquitylated in response to genotoxin treatment. We have shown that the ubiquitin-mediated degradation of topoisomerase I is inhibited in camptothecin (anticancer genotoxic agent) treated A-T cells (37) . Several other proteins (e.g., RNA pol II 0 and Mcm10) are ubiquitylated and degraded in response to UV treatment (61, 62) . Whether the targeted degradation of these proteins is impaired in UVtreated A-T cells is not studied; however, the published results in different cell lineages point towards such a possibility. Inability of the dysfunctional ubiquitin pathway to degrade these UV-damaged proteins may increase autophagic demand to degrade these proteins, resulting in over induction of autophagy in UV-exposed A-T cells. Increased autophagic flux may reduce cellular reserves hence induce autophagic stress and A-T cell death. Concurrently, autophagy is activated (15, 63, 64) and autophagic stress in neurons leads to neuronal cell death in various proteinopathyinduced neuronal disorders (65, 66) .
Our results are highly relevant for improving the health status of A-T patients who are constantly exposed to the environmental genotoxic agents such as sunlight, viral infections, high temperature, and human made mutagenic chemicals during their life time. In addition, A-T patients are also vulnerable to oxidative stress (69) which can also lead to protein damage. Hence, it is reasonable that genotoxic agents and oxidative stress can induce autophagic stress in A-T neurons which, in turn, lead to their autophagic death. Thus far, the hypersensitivity to the genotoxic stress has been principally linked to defective DNA repair in A-T. Our current results suggest that in addition to the deregulated DNA repair, deregulation of the protein turnover may in part also contribute to the genotoxic stress-mediated hypersensitivity in A-T patients. Knowing that constitutively elevated ISG15 is causally related to the deregulation of both the major protein turnover pathways in A-T fibroblast cells provides an opportunity to target the ISG15 pathway to reduce neurodegeneration and ataxia associated with it in A-T patients. Also, attenuating autophagy with the pharmacological inhibitors (e.g. 3-MA) could prevent neurodegeneration in A-T. These studies thus have potential clinical applications for treating A-T patients. This is particularly important since there is no cure or preventive medicines available for treating A-T. (A) A-T and ATM+ cells were exposed to different doses of UV and allowed to recover for three hours. Cells were lysed and lysates were analyzed by Western blotting for polyubiquitylated proteins and tubulin using anti-ubiquitin and anti-tubulin antibodies respectively. (B) A-T and ATM+ cells were transfected with a HA-ubiquitin construct. Cells were then treated with MG132 (1 µM) or Bafl (1 nM) for 18 hours and exposed to UV radiation (25 mJ/m 2 ). After recovery in the presence of inhibitors for an additional three hours, cells were lysed. Cell extracts were analyzed by Western blotting for HApolyubiquitylated proteins and actin using anti-HA and anti-actin antibodies respectively. Intensity of the total HA-polyubiquitylated proteins was quantitated using BioRad Quantity One software. The bar graph shows average values (± SEM) of % degradation of HA-polyubiquitylated proteins from three independent experiments. (C) A-T and ATM+ cells were transfected with HA-Lys 48 only ubiquitin construct. The inhibitor and UV treatments, cell lysis, SDS-PAGE, and immunoblotting analysis to detect HA-ubiquitin conjugated proteins using anti-HA antibodies was carried out as described in (B). The experiment was repeated two times with the reproducible results. (D) A-T cells were treated with camptothecin (10 µm) in the presence or absence of Bafl (1 nm) for 24 hrs. Ubiquitin conjugated proteins using anti-ubiquitin antibodies were detected as described in (A). Experiment was repeated three times and the two-tailed p values are presented in the text. . After three hours of recovery, assessment of HA-polyubiquitylated proteins was carried out as described in the legend to Figure 1 (B). (C) HA-ubiquitin-transfected A-T/LV-control shRNA cells were treated with Bafl (1 nm for 18 hrs). Cells were then exposed to UV (25 mJ/m 2 ). After three hours of recovery in the presence of the inhibitor, assessment of HA-polyubiquitylated proteins was carried out as described in (B). (D) HAubiquitin-transfected A-T/LV-control shRNA cells were treated with MG132 (1 nm for 18 hrs). Cells were then exposed to UV (25 mJ/m 2 ). After three hours of recovery in the presence of the inhibitor, assessment of HA-polyubiquitylated proteins was carried out as described in (B). (E) HA-ubiquitintransfected A-T/LV-control shRNA cells were treated with 3-MA (10 nm for 18 hrs). Cells were then exposed to UV (25 mJ/m 2 ). After three hours of recovery in the presence of the inhibitor, assessment of HA-polyubiquitylated proteins was carried out as described in (B). All experiments shown in panels B-E were performed at least three times and yielded similar results. . Cells were then exposed to UV (25 mJ/m 2 ). After three hours of recovery in the presence of the inhibitor, assessment of HA-polyubiuitylated proteins was carried out as described in (B). (D) HA-ubiquitin-transfected A-T/LV-control shRNA cells were treated with MG132 (1 nm for 18 hrs). Cells were then exposed to UV (25 mJ/m 2 ). After three hours of recovery in the presence of inhibitor, assessment of HA-polyubiuitylated proteins was carried out as described in (B). All experiments shown in panels B-D were performed at least three times and yielded similar results. by guest on November 15, 2017 
